OM
EIDX
Opaleye Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-315,550
| Closed | -$41.5M | – | 74 |
|
|
2020
Q4 | $41.5M | Hold |
315,550
| – | – | 5.42% | 3 |
|
|
2020
Q3 | $15.9M | Hold |
315,550
| – | – | 3.12% | 10 |
|
|
2020
Q2 | $14.6M | Hold |
315,550
| – | – | 2.96% | 9 |
|
|
2020
Q1 | $15.5M | Hold |
315,550
| – | – | 4.1% | 7 |
|
|
2019
Q4 | $18.1M | Buy |
315,550
+10,000
| +3% | +$574K | 3.55% | 9 |
|
|
2019
Q3 | $11M | Hold |
305,550
| – | – | 3.97% | 5 |
|
|
2019
Q2 | $9.5M | Buy |
305,550
+105,550
| +53% | +$3.28M | 2.89% | 15 |
|
|
2019
Q1 | $4.69M | Buy |
200,000
+60,000
| +43% | +$1.41M | 1.3% | 32 |
|
|
2018
Q4 | $1.93M | Buy |
+140,000
| New | +$1.93M | 0.72% | 34 |
|